Safety, Efficacy, and Relapse of Nirmatrelvir-Ritonavir in Kidney Transplant Recipients Infected With SARS-CoV-2

Kidney International Reports(2022)

引用 15|浏览15
暂无评分
摘要
NR can be used in KTRs but requires a strict protocol of drug adaptation. We observed 2 cases of early relapse after NR treatment that need further investigations.
更多
查看译文
关键词
efficacy,kidney transplantation,nirmatrelvir-ritonavir,relapse,safety,SARS-CoV-2
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要